Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Intrapulmonary pharmacokinetics and pharmacodynamics of micafungin in adult lung transplant patients.

Walsh TJ, Goutelle S, Jelliffe RW, Golden JA, Little EA, DeVoe C, Mickiene D, Hayes M, Conte JE Jr.

Antimicrob Agents Chemother. 2010 Aug;54(8):3451-9. doi: 10.1128/AAC.01647-09. Epub 2010 May 3.

2.

Effects of immunomodulatory and organism-associated molecules on the permeability of an in vitro blood-brain barrier model to amphotericin B and fluconazole.

Pyrgos V, Mickiene D, Sein T, Cotton M, Fransesconi A, Mizrahi I, Donoghue M, Bundrant N, Kim SY, Hardwick M, Shoham S, Walsh TJ.

Antimicrob Agents Chemother. 2010 Mar;54(3):1305-10. doi: 10.1128/AAC.01263-09. Epub 2009 Dec 7.

3.

Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis.

Petraitis V, Petraitiene R, Hope WW, Meletiadis J, Mickiene D, Hughes JE, Cotton MP, Stergiopoulou T, Kasai M, Francesconi A, Schaufele RL, Sein T, Avila NA, Bacher J, Walsh TJ.

Antimicrob Agents Chemother. 2009 Jun;53(6):2382-91. doi: 10.1128/AAC.00329-09. Epub 2009 Mar 23.

4.

Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis.

Petraitiene R, Petraitis V, Hope WW, Mickiene D, Kelaher AM, Murray HA, Mya-San C, Hughes JE, Cotton MP, Bacher J, Walsh TJ.

Antimicrob Agents Chemother. 2008 Nov;52(11):4121-9. doi: 10.1128/AAC.00674-08. Epub 2008 Sep 8.

5.

The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates.

Hope WW, Mickiene D, Petraitis V, Petraitiene R, Kelaher AM, Hughes JE, Cotton MP, Bacher J, Keirns JJ, Buell D, Heresi G, Benjamin DK Jr, Groll AH, Drusano GL, Walsh TJ.

J Infect Dis. 2008 Jan 1;197(1):163-71. doi: 10.1086/524063.

6.

Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy.

Hope WW, Kruhlak MJ, Lyman CA, Petraitiene R, Petraitis V, Francesconi A, Kasai M, Mickiene D, Sein T, Peter J, Kelaher AM, Hughes JE, Cotton MP, Cotten CJ, Bacher J, Tripathi S, Bermudez L, Maugel TK, Zerfas PM, Wingard JR, Drusano GL, Walsh TJ.

J Infect Dis. 2007 Feb 1;195(3):455-66. Epub 2006 Dec 21.

PMID:
17205486
7.

Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations.

Groll AH, Lyman CA, Petraitis V, Petraitiene R, Armstrong D, Mickiene D, Alfaro RM, Schaufele RL, Sein T, Bacher J, Walsh TJ.

Antimicrob Agents Chemother. 2006 Oct;50(10):3418-23.

8.

Measurement of amphotericin B concentration by resonant Raman spectroscopy--a novel technique that may be useful for non-invasive monitoring.

La Via WV, Lambert JL, Pelletier MJ, Morookian JM, Sirk SJ, Mickiene D, Walsh TJ, Borchert MS.

Med Mycol. 2006 Mar;44(2):169-74.

PMID:
16519020
9.

Compartmental pharmacokinetics and tissue distribution of the antifungal triazole ravuconazole following intravenous administration of its di-lysine phosphoester prodrug (BMS-379224) in rabbits.

Groll AH, Mickiene D, Petraitis V, Petraitiene R, Kelaher A, Sarafandi A, Wuerthwein G, Bacher J, Walsh TJ.

J Antimicrob Chemother. 2005 Nov;56(5):899-907. Epub 2005 Sep 19.

PMID:
16172108
10.

Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits.

Petraitiene R, Petraitis V, Kelaher AM, Sarafandi AA, Mickiene D, Groll AH, Sein T, Bacher J, Walsh TJ.

Antimicrob Agents Chemother. 2005 May;49(5):2084-92.

11.

Efficacy and safety of generic amphotericin B in experimental pulmonary aspergillosis.

Petraitis V, Petraitiene R, Lin P, Calis K, Kelaher AM, Muray HA, Mya-San C, Mickiene D, Bacher J, Walsh TJ.

Antimicrob Agents Chemother. 2005 Apr;49(4):1642-5.

12.

Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans.

Petraitis V, Petraitiene R, Kelaher AM, Sarafandi AA, Sein T, Mickiene D, Bacher J, Groll AH, Walsh TJ.

Antimicrob Agents Chemother. 2004 Oct;48(10):3959-67.

13.

Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.

Petraitiene R, Petraitis V, Lyman CA, Groll AH, Mickiene D, Peter J, Bacher J, Roussillon K, Hemmings M, Armstrong D, Avila NA, Walsh TJ.

Antimicrob Agents Chemother. 2004 Apr;48(4):1188-96.

14.

Comparative drug disposition, urinary pharmacokinetics, and renal effects of multilamellar liposomal nystatin and amphotericin B deoxycholate in rabbits.

Groll AH, Mickiene D, Petraitis V, Petraitiene R, Alfaro RM, King C, Piscitelli SC, Walsh TJ.

Antimicrob Agents Chemother. 2003 Dec;47(12):3917-25.

15.

Safety, pharmacokinetics, and pharmacodynamics of cyclodextrin itraconazole in pediatric patients with oropharyngeal candidiasis.

Groll AH, Wood L, Roden M, Mickiene D, Chiou CC, Townley E, Dad L, Piscitelli SC, Walsh TJ.

Antimicrob Agents Chemother. 2002 Aug;46(8):2554-63.

16.

Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits.

Groll AH, Mickiene D, Petraitis V, Petraitiene R, Ibrahim KH, Piscitelli SC, Bekersky I, Walsh TJ.

Antimicrob Agents Chemother. 2001 Dec;45(12):3322-7.

17.

Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling.

Groll AH, Mickiene D, Petraitiene R, Petraitis V, Lyman CA, Bacher JS, Piscitelli SC, Walsh TJ.

Antimicrob Agents Chemother. 2001 Oct;45(10):2845-55.

18.

Compartmental pharmacokinetics and tissue distribution of multilamellar liposomal nystatin in rabbits.

Groll AH, Mickiene D, Werner K, Petraitiene R, Petraitis V, Calendario M, Field-Ridley A, Crisp J, Piscitelli SC, Walsh TJ.

Antimicrob Agents Chemother. 2000 Apr;44(4):950-7.

19.

Distribution of lipid formulations of amphotericin B into bone marrow and fat tissue in rabbits.

Groll AH, Mickiene D, Piscitelli SC, Walsh TJ.

Antimicrob Agents Chemother. 2000 Feb;44(2):408-10.

20.

High-performance liquid chromatographic determination of liposomal nystatin in plasma and tissues for pharmacokinetic and tissue distribution studies.

Groll AH, Mickiene D, Werner K, Piscitelli SC, Walsh TJ.

J Chromatogr B Biomed Sci Appl. 1999 Nov 26;735(1):51-62.

PMID:
10630890

Supplemental Content

Loading ...
Support Center